High-throughput, Multiplexed Detection of miRNA Biomarkers in Single Cancer Cells

单癌细胞中 miRNA 生物标志物的高通量多重检测

基本信息

  • 批准号:
    8546663
  • 负责人:
  • 金额:
    $ 24.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are a class of small non-coding RNAs recently discovered as negative gene regulators. A large faction of miRNAs are located within the fragile regions of chromosomes, which are areas of the genome more tightly associated with human cancers, indicating the possible role of miRNAs in tumor development. It has been shown that miRNA expression profiles correlate with various cancers and the miRNA signatures are potentially unique cancer biomarkers to accurately diagnose and classify human cancers. However, human cancers are highly heterogeneous due in part to the high degree of intratumoral heterogeneity at the single-cell level, requiring the evaluation of a large number of single tumor cells, each of which the miRNA expression profile can be measured. Here we propose to combine a single-cell barcode chip platform and a novel ligation-based miRNA detection scheme to develop an innovative technology that for the first time offers both high-throughput and multiplexing for rapid miRNA detection in single cells without amplification and at low cost. More specifically, we will: (1) Design and validate a DNA barcode microarray for multiplexed detection of miRNA biomarkers without amplification, and (2) Integrate this barcode array with a nanoliter microfluidics chip to perform multiplexed detection of 12 miRNA biomarkers from a large number of single cancer cells. Our technology is a versatile platform to detect miRNA biomarkers implicated in a variety of human cancers. It can be further modified to detect other non-encoding RNAs and messenger RNA biomarkers from single cells. Moreover, the proposed microchip is inexpensive, scalable and easy to manufacture. It may find immediate applications in basic research and clinical stratification of human cancers.
描述(由申请人提供):微小RNA(miRNAs)是最近发现的一类小的非编码RNA,作为负基因调节因子。大部分miRNA位于染色体的脆弱区域内,这些区域是与人类癌症更紧密相关的基因组区域,表明miRNA在肿瘤发展中的可能作用。研究表明,miRNA的表达谱与多种癌症相关,miRNA标志物是一种潜在的独特的癌症生物标志物,可用于人类癌症的准确诊断和分类。然而,人类癌症是高度异质性的,部分原因是在单细胞水平上肿瘤内的高度异质性,需要评估大量的单个肿瘤细胞,每个肿瘤细胞的miRNA表达谱都可以测量。在这里,我们提出了联合收割机结合单细胞条形码芯片平台和一种新的基于连接的miRNA检测方案,以开发一种创新技术,首次提供高通量和多路复用,用于在单细胞中快速检测miRNA,而无需扩增,成本低。具体而言,我们将:(1)设计并验证用于多重检测miRNA生物标志物而不扩增的DNA条形码微阵列,以及(2)将该条形码阵列与纳升微流体芯片整合以执行来自大量单个癌细胞的12种miRNA生物标志物的多重检测。我们的技术是一个多功能的平台,可以检测与各种人类癌症有关的miRNA生物标志物。它可以被进一步修饰以检测来自单细胞的其他非编码RNA和信使RNA生物标志物。此外,所提出的微芯片是廉价的,可扩展的,易于制造。它可能会立即应用于人类癌症的基础研究和临床分层。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick S Doyle其他文献

Patrick S Doyle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick S Doyle', 18)}}的其他基金

Microengineered Technologies for Quantitative, Multiplexed and Spatially Resolved Measurement of miRNA in Tissue Sections
用于组织切片中 miRNA 的定量、多重和空间分辨测量的微工程技术
  • 批准号:
    10172873
  • 财政年份:
    2019
  • 资助金额:
    $ 24.46万
  • 项目类别:
Microengineered Technologies for Quantitative, Multiplexed and Spatially Resolved Measurement of miRNA in Tissue Sections
用于组织切片中 miRNA 的定量、多重和空间分辨测量的微工程技术
  • 批准号:
    10407515
  • 财政年份:
    2019
  • 资助金额:
    $ 24.46万
  • 项目类别:
Microengineered Technologies for Quantitative, Multiplexed and Spatially Resolved Measurement of miRNA in Tissue Sections
用于组织切片中 miRNA 的定量、多重和空间分辨测量的微工程技术
  • 批准号:
    10626081
  • 财政年份:
    2019
  • 资助金额:
    $ 24.46万
  • 项目类别:
High-throughput, Multiplexed Detection of miRNA Biomarkers in Single Cancer Cells
单癌细胞中 miRNA 生物标志物的高通量多重检测
  • 批准号:
    8726351
  • 财政年份:
    2013
  • 资助金额:
    $ 24.46万
  • 项目类别:
Multiplexed Encoded Particle PCR for Rapid Panel Diagnosis of Sexually-Transmitte
用于性传播疾病快速组合诊断的多重编码粒子 PCR
  • 批准号:
    7803524
  • 财政年份:
    2010
  • 资助金额:
    $ 24.46万
  • 项目类别:
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
基于水凝胶颗粒的 microRNA 分析用于发现和癌症诊断
  • 批准号:
    8126610
  • 财政年份:
    2009
  • 资助金额:
    $ 24.46万
  • 项目类别:
Barcoded Hydrogel Microparticles and Scanner for Multiplexed Biomolecule Assays
用于多重生物分子检测的条形码水凝胶微粒和扫描仪
  • 批准号:
    7777791
  • 财政年份:
    2009
  • 资助金额:
    $ 24.46万
  • 项目类别:
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
基于水凝胶颗粒的 microRNA 分析用于发现和癌症诊断
  • 批准号:
    8304197
  • 财政年份:
    2009
  • 资助金额:
    $ 24.46万
  • 项目类别:
Barcoded Hydrogel Microparticles and Scanner for Multiplexed Biomolecule Assays
用于多重生物分子检测的条形码水凝胶微粒和扫描仪
  • 批准号:
    7659888
  • 财政年份:
    2009
  • 资助金额:
    $ 24.46万
  • 项目类别:
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
基于水凝胶颗粒的 microRNA 分析用于发现和癌症诊断
  • 批准号:
    7747007
  • 财政年份:
    2009
  • 资助金额:
    $ 24.46万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 24.46万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 24.46万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 24.46万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 24.46万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 24.46万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 24.46万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 24.46万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 24.46万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 24.46万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 24.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了